Chronic cough and cough hypersensitivity: from mechanistic insights to novel antitussives
Authors:
- 10 November 2022
- journal article
- editorial
- Published by Elsevier in The Lancet Respiratory Medicine
- Vol. 10 (12) , 1113-1115
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trialsThe Lancet, 2022
- Assessing cough symptom severity in refractory or unexplained chronic cough: findings from patient focus groups and an international expert panelERJ Open Research, 2022
- Prevalence and Burden of Chronic Cough in the United StatesThe Journal of Allergy and Clinical Immunology: In Practice, 2021
- Cough symptom severity in patients with refractory or unexplained chronic cough: a systematic survey and conceptual frameworkEuropean Respiratory Review, 2021
- Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responsesThe Lancet Respiratory Medicine, 2021
- Performance of a digital signal processing algorithm for the accurate quantification of cough frequencyEuropean Respiratory Journal, 2021
- Exhaled aerosol increases with COVID-19 infection, age, and obesityProceedings of the National Academy of Sciences, 2021
- Burden of Specialist-Diagnosed Chronic Cough in AdultsThe Journal of Allergy and Clinical Immunology: In Practice, 2020
- Mycobacterium tuberculosis Sulfolipid-1 Activates Nociceptive Neurons and Induces CoughCell, 2020
- Capsaicin-evoked cough responses in asthmatic patients: Evidence for airway neuronal dysfunctionJournal of Allergy and Clinical Immunology, 2017